• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Stryker enters 2023 with good momentum — and Mako news

Stryker enters 2023 with good momentum — and Mako news

February 1, 2023 By Chris Newmarker

Stryker logoStryker (NYSE:SYK) reported fourth-quarter results that beat The Street, predicting up to 8.5% organic sales growth in the new year.

CEO Kevin Lobo also had a timeline of future application launches for the ortho device giant’s popular Mako robotic surgery system.

The results, posted yesterday evening, sent SYK shares up more than 6% to $271.26 apiece by midday trading today.

The Kalamazoo, Michigan–based company earned $563 million, or $1.47 per share, off of $5.2 billion in sales for the quarter that ended Dec. 31, 2022. The results represented a bottom-line slide of 15.0% compared with Q4 2021. However, sales were up 10.7.

Adjusted to exclude one-time items, EPS were $3. The amount was 16¢ ahead of Wall Street expectations, where analysts predicted EPS of $2.84 and sales of $4.96 billion.

“We delivered outstanding organic sales growth in the fourth quarter, driven by strong commercial execution and improved supply,” Lobo said in a news release. “We expect continued positive sales momentum in 2023 and for adjusted earnings to gradually improve over the course of the year.”

MedSurg and Neurotechnology sales in Q4 were $3.1 billion, up 15.6% year over year. Orthopaedics and Spine sales were $2.2 billion, up 4.3%.

Stryker is experiencing good momentum — and building excitement around Mako

Stryker officials expect the company to experience more macroeconomic volatility in 2023. Their earnings release mentioned alleviating supply chain disruptions, inflationary risks and currency fluctuations.

But despite the uncertainty, Stryker also reported good momentum in many parts of its business heading into 2023. The company is predicting organic net sales growth of 7–8.5% and adjusted EPS of $9.85–10.15 in 2023. (Analysts, on average, have predicted EPS of $9.86 for the full-year 2023.)

BTIG analysts stuck with their Buy rating for Stryker stock. Their note had the subhead: “ABC … Always Be Closing.”

“EPS is showing little to no leverage relative to organic growth, but we think as SYK moves through the year, the combination of a robust product cadence, improving procedural dynamics, a strong order book, and expense control puts SYK in a position to show upside,” said BTIG’s Ryan Zimmerman and Sam Durno.

The BTIG analysts also noted that there should be growing excitement this year around the future expansion of applications around Stryker’s popular Mako line of ortho surgery robots.

Lobo reported good progress around new Mako applications during the company’s earnings call. The company expects Mako Spine to initially launch in the second half of 2024, with Mako Shoulder out by the end of 2024.’

“What gives us confidence is our prototypes are built,” Lobo said. “We have tested it with surgeons. We have gotten feedback. We have had some meetings in one case with the agency to get an idea on the regulatory pathway.”

This story originally ran on Jan. 31, 2022. Updated Feb. 1 with the next-day stock price, and analyst comment. 

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, News Well, Orthopedics, Spine, Surgical, Wall Street Beat Tagged With: Stryker

More recent news

  • Vicarious Surgical inks surgical robot collab with hospital, eyes first clinical patients
  • Bioliberty launches hub for soft-robotic wearable devices
  • Zynex submits laser pulse oximeter to FDA
  • Roche invests $550M to make Indianapolis a CGM manufacturing hub
  • Product liability lawsuits target Medtronic, Boston Scientific spinal cord stim tech

About Chris Newmarker

Chris Newmarker is the executive editor of WTWH Media life science's news websites and publications including MassDevice, Medical Design & Outsourcing and more. A professional journalist of 18 years, he is a veteran of UBM (now Informa) and The Associated Press whose career has taken him from Ohio to Virginia, New Jersey and, most recently, Minnesota. He’s covered a wide variety of subjects, but his focus over the past decade has been business and technology. He holds bachelor’s degrees in journalism and political science from Ohio State University. Connect with him on LinkedIn or email at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy